Riskpilot← Back to searchSign inGet full accessJK
James Kelly Ganjei
SE0 active roles
Active roles
0
directorships & management
Past roles
4
historical positions
Dissolved companies
1
in directorship history
- 2020 – 2021Chairman, NXbio Development AB
- 2020 – 2021Chairman, NorthX Biologics AB
- 2020 – 2021Chairman, Charles River Laboratories Sweden AB
- 2020 – 2021Chairman, Cobra Biologics Holding AB
Nationality
SE
| Company | Role | Period | Ownership | Status |
|---|
| Company | Role | Period | Ownership | Status |
|---|---|---|---|---|
| NXbio Development AB CVR 5565121794 | BoardChairman | 2020 – 2021 | — | Active |
| NorthX Biologics AB CVR 5566617816 | BoardChairman | 2020 – 2021 | — | Active |
| Charles River Laboratories Sweden AB CVR 5567671366 | BoardChairman | 2020 – 2021 | — | Active |
| Cobra Biologics Holding AB CVR 5568566631 | BoardChairman | 2020 – 2021 | — | Dissolved |
1 dissolved company in directorship history
Cobra Biologics Holding AB
CVR 5568566631 · Dissolved 2021 · —
| Person | Role | Shared companies | Profile |
|---|---|---|---|
| Chief Executive Officer | 3companies | View profile | |
| Board of Directors | 3companies | View profile | |
| Chief Executive Officer | 3companies | View profile | |
| Chief Auditor | 3companies | View profile | |
| Board of Directors | 2companies | View profile |
James Kelly Ganjei